IL99905A - Topical compositions for transdermal delivery of morphine prodrugs - Google Patents

Topical compositions for transdermal delivery of morphine prodrugs

Info

Publication number
IL99905A
IL99905A IL9990591A IL9990591A IL99905A IL 99905 A IL99905 A IL 99905A IL 9990591 A IL9990591 A IL 9990591A IL 9990591 A IL9990591 A IL 9990591A IL 99905 A IL99905 A IL 99905A
Authority
IL
Israel
Prior art keywords
morphine
transdermal delivery
hydrogen
formula
topical
Prior art date
Application number
IL9990591A
Other languages
English (en)
Other versions
IL99905A0 (en
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of IL99905A0 publication Critical patent/IL99905A0/xx
Publication of IL99905A publication Critical patent/IL99905A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL9990591A 1990-11-16 1991-10-30 Topical compositions for transdermal delivery of morphine prodrugs IL99905A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003665A SE9003665D0 (sv) 1990-11-16 1990-11-16 Morphine prodrugs

Publications (2)

Publication Number Publication Date
IL99905A0 IL99905A0 (en) 1992-08-18
IL99905A true IL99905A (en) 1995-06-29

Family

ID=20380936

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9990591A IL99905A (en) 1990-11-16 1991-10-30 Topical compositions for transdermal delivery of morphine prodrugs

Country Status (18)

Country Link
US (1) US5908846A (pt)
EP (1) EP0557385B1 (pt)
JP (1) JP3493434B2 (pt)
AT (1) ATE168560T1 (pt)
AU (1) AU655612B2 (pt)
CA (1) CA2095223C (pt)
DE (1) DE69129861T2 (pt)
DK (1) DK0557385T3 (pt)
ES (1) ES2121793T3 (pt)
FI (1) FI932212A (pt)
IE (1) IE913682A1 (pt)
IL (1) IL99905A (pt)
NO (1) NO931766L (pt)
NZ (1) NZ240349A (pt)
PT (1) PT99513B (pt)
SE (1) SE9003665D0 (pt)
WO (1) WO1992008459A1 (pt)
ZA (1) ZA918512B (pt)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607691A (en) * 1992-06-12 1997-03-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
DE4403709A1 (de) * 1994-02-07 1995-08-10 Lohmann Therapie Syst Lts Pharmazeutische Zusammensetzung zur systemischen transdermalen Verabreichung mit dem Wirkstoff Morphin-6-glucuronid
JPH07267862A (ja) * 1994-03-29 1995-10-17 Sekisui Chem Co Ltd 経皮吸収貼付剤
WO1996028451A1 (en) * 1995-03-14 1996-09-19 Euroceltique S.A. Morphine-3-esters
DE19508664C2 (de) * 1995-03-14 2001-08-23 Christian Mignat Verwendung von Morphin-3-estern, Morphin-3-ester als solche und Verfahren zu deren Herstellung
GB9519363D0 (en) 1995-09-22 1995-11-22 Euro Celtique Sa Pharmaceutical formulation
DE19602968A1 (de) * 1995-12-20 1997-07-31 Nycomed Arzneimittel Gmbh Neue Morphinderivate, Verfahren zu deren Herstellung und deren Verwendung
DE19923551A1 (de) * 1999-05-21 2000-11-30 Lohmann Therapie Syst Lts Pharmazeutisches Präparat mit dem Wirkstoff Diamorphin und seine Verwendung in einem Verfahren zur Behandlung der Opiatsucht
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
CA2389235C (en) 1999-10-29 2007-07-17 Euro-Celtique, S.A. Controlled release hydrocodone formulations
US20020013331A1 (en) * 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane
EP2283829A1 (en) 2000-10-30 2011-02-16 Euro-Celtique S.A. Controlled release hydrocodone formulations
US6569449B1 (en) * 2000-11-13 2003-05-27 University Of Kentucky Research Foundation Transdermal delivery of opioid antagonist prodrugs
AUPR549901A0 (en) * 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
WO2002040034A1 (en) * 2000-11-14 2002-05-23 Vital Health Sciences Pty Ltd. Complexes of phosphate derivatives
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
TWI255186B (en) * 2001-06-05 2006-05-21 Control Delivery Sys Inc Sustained-release analgesic compounds
JP4745608B2 (ja) * 2001-07-27 2011-08-10 バイタル ヘルス サイエンシズ プロプライアタリー リミティド 電子伝達剤のリン酸誘導体を用いた皮膚治療
DE60238276D1 (de) * 2001-12-13 2010-12-23 Vital Health Sciences Pty Ltd Transdermaler transport von verbindungen
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
AU2003285934A1 (en) * 2002-10-25 2004-05-25 Euro-Celtique S.A. Analogs and prodrugs of buprenorphine
WO2004043396A2 (en) * 2002-11-09 2004-05-27 Nobex Corporation Modified carbamate-containing prodrugs and methods of synthesizing same
WO2004064831A1 (en) * 2003-01-17 2004-08-05 Vital Health Sciences Pty Ltd Compounds having anti-proliferative properties
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
CA2529983C (en) * 2003-07-25 2010-07-20 Bruce E. Reidenberg Preoperative treatment of post operative pain
ATE451374T1 (de) 2004-02-06 2009-12-15 Euro Celtique Sa Verfahren zur herstellung 3-o-geschützter morphinone und 3-o-geschützter morphinon-dienol- carboxylate
JP2007523167A (ja) 2004-02-23 2007-08-16 ユーロ−セルティーク エス．エイ． 乱用抵抗性の経皮的オピオイド送達デバイス
NZ549567A (en) 2004-03-03 2009-10-30 Vital Health Sciences Pty Ltd Formulations comprising a tocopheryl phosphate tertiary amine alkaloid complex
WO2006133506A1 (en) * 2005-06-17 2006-12-21 Vital Health Sciences Pty Ltd A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
CA2631653A1 (en) * 2005-12-23 2007-06-28 Vital Health Sciences Pty Ltd. Compounds having cytokine modulating properties
US9326979B2 (en) 2007-03-02 2016-05-03 Teika Pharmaceutical Co., Ltd. Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same
US9511016B2 (en) * 2007-06-12 2016-12-06 Epicentrx, Inc. Topical composition for treating pain
US8354116B2 (en) * 2007-06-18 2013-01-15 Biochemics, Inc. Bifunctional synthetic molecules
US8784872B2 (en) 2007-11-19 2014-07-22 Comgenrx, Inc. Formulation for decreasing tobacco, alcohol, drug or food consumption
US20090130048A1 (en) * 2007-11-19 2009-05-21 Oronsky Bryan Todd Topical Composition for Treating Pain
US20100104614A1 (en) * 2008-06-27 2010-04-29 Oronsky Bryan T Providone compositions for wound healing
UA102916C2 (uk) 2009-07-02 2013-08-27 Кемфарм, Інк. Композиція на основі кон'югату гідрокодону з бензойною кислотою, похідними бензойної кислоти або гетероарилкарбоновою кислотою, проліки, спосіб лікування від зловживань
US10849981B2 (en) 2009-07-02 2020-12-01 KemPham, Inc. Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof
CA2765836C (en) * 2009-07-02 2014-10-07 Kempharm, Inc. Phenylethanoic acid, phenylpropanoic acid and phenylpropenoic acid conjugates and prodrugs of hydrocodone, methods of making and use thereof
US10071030B2 (en) 2010-02-05 2018-09-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
MX2012011355A (es) 2010-03-30 2012-11-30 Phosphagenics Ltd Parche de suministro transdermico.
AU2011239636A1 (en) 2010-04-13 2012-11-22 Najib Babul Dermal pharmaceutical compositions of 1-Methyl-2',6'-pipecoloxylidide and method of use
TWI520732B (zh) 2011-01-18 2016-02-11 輝瑞有限公司 固體分子分散液
WO2012122586A1 (en) 2011-03-15 2012-09-20 Phosphagenics Limited New composition
AU2015353502B2 (en) 2014-11-25 2018-09-27 Kempharm, Inc. Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodone
JP6882321B2 (ja) 2015-12-09 2021-06-02 フォスファージニクス リミテッド 医薬製剤
NZ754168A (en) 2016-12-21 2024-08-30 Avecho Biotechnology Ltd Process for phosphorylating a complex alcohol

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4673679A (en) * 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
US4908389A (en) * 1986-08-27 1990-03-13 Warner-Lambert Company Penetration enhancement system
US4940586A (en) * 1987-02-26 1990-07-10 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4879297A (en) * 1987-06-01 1989-11-07 Warner-Lambert Company Fatty acids and their small chain esters as penetration enhancers in aqueous systems
US4891377A (en) * 1988-12-02 1990-01-02 Board Of Regents Acting For And On Behalf Of University Of Michigan Transdermal delivery of the narcotic analgesics etorphine and analogs
WO1991015241A1 (en) * 1990-03-30 1991-10-17 Yasunori Morimoto Percutaneously absorbable composition of narcotic and nonnarcotic analgesics
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine

Also Published As

Publication number Publication date
JPH06502422A (ja) 1994-03-17
WO1992008459A1 (en) 1992-05-29
ATE168560T1 (de) 1998-08-15
DK0557385T3 (da) 1999-04-26
NO931766D0 (no) 1993-05-14
FI932212A0 (fi) 1993-05-14
DE69129861T2 (de) 1999-04-01
EP0557385A1 (en) 1993-09-01
ZA918512B (en) 1992-08-26
JP3493434B2 (ja) 2004-02-03
PT99513B (pt) 1999-04-30
US5908846A (en) 1999-06-01
PT99513A (pt) 1992-09-30
SE9003665D0 (sv) 1990-11-16
AU8938191A (en) 1992-06-11
CA2095223C (en) 2002-12-17
CA2095223A1 (en) 1992-05-17
NO931766L (no) 1993-05-14
FI932212A (fi) 1993-05-14
AU655612B2 (en) 1995-01-05
IE913682A1 (en) 1992-05-20
ES2121793T3 (es) 1998-12-16
DE69129861D1 (de) 1998-08-27
NZ240349A (en) 1993-07-27
EP0557385B1 (en) 1998-07-22
IL99905A0 (en) 1992-08-18

Similar Documents

Publication Publication Date Title
AU655612B2 (en) Topical compositions for transdermal delivery of produg derivatives of morphine
EP1962817B1 (en) Transdermal delivery of a salt form of meptazinol
KR100413202B1 (ko) 경피흡수제제
US4879297A (en) Fatty acids and their small chain esters as penetration enhancers in aqueous systems
Bucks Skin structure and metabolism: relevance to the design of cutaneous therapeutics
US4663349A (en) Rectally absorbable form of L-dopa
DE3382795T2 (de) Gehirnspezifische arzneimittelabgabe.
GB2153223A (en) Composition for percutaneously administering metoclopramide
CA2559640A1 (en) Means for transdermal administration of nicotine
EP0375689A1 (en) A PHARMACEUTICAL COMPOSITION ADAPTED TO THE TRANSDERMAL APPLICATION OF AN OPIOID.
US20100222309A1 (en) Skin property-improving therapeutic agent comprising a morphinan derivative or any of its pharmacologically permissible acid addition salts as an active ingredient
US6703398B2 (en) Orally administered analgesic compositions containing nalbuphine
US5405834A (en) Prodrug derivatives of thyrotropin-releasing hormone (TRH)
EP0651993B1 (en) Percutaneously administrable base composition and drug composition prepared therefrom
US20220249470A1 (en) Treatment of skin disorders by topical administration of vegf inhibitors
US4328231A (en) Method of treating psoriasis
FR2556216A1 (fr) Nouveau medicament analgesique contenant du proglumide, eventuellement en association avec des medicaments analgesiques-narcotiques
WO1992022530A1 (en) Ketobemidone prodrugs
JP2002506803A (ja) 潤いを与える組成物
US20090270437A1 (en) Use of Buprenorphine or N-Alkylated Derivatives Thereof for Wound Healing
JP2017186329A (ja) 皮膚色素沈着抑制剤
Birnbaum et al. Cutaneous erythema and blood pressure lowering effects of topically applied 16-vinylprostaglandins
IL95528A (en) Topical antiinflammatory compositions with minimal systemic absorption containing indole or naphtol derivatives
US5246949A (en) Preparation for endermism containing dopamine derivatives
WO1991000728A1 (en) Benzophenanthridine alkaloids for topical acne treatment

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees